VisibilityRx

VisibilityRx operates as a specialized service provider focused on patient identification and communication, primarily for the clinical research sector. Founded in 2010, the company established itself by developing solutions to streamline the process of finding and engaging with patients for various healthcare initiatives. In a significant milestone, VisibilityRx was acquired by DrFirst, a company specializing in e-prescribing and medication management, on January 31, 2017. This acquisition was aimed at integrating VisibilityRx's patient matching capabilities with DrFirst's extensive network of physician clients to optimize clinical trial recruitment.

The core of VisibilityRx's business is to reduce the time and costs associated with patient recruitment, a significant expenditure in clinical trials. The company serves a diverse client base that includes pharmaceutical manufacturers, clinical research organizations (CROs), and market research firms. Its business model centers on providing services such as patient identification, recruitment, call center management, and survey hosting. A key feature of its offering is the use of proprietary, HIPAA-compliant technology to create de-identified patient databases. This technology allows clients to identify potential study participants based on specific inclusion and exclusion criteria by leveraging actual patient attributes. Initially, the company's technology focused on the relationships between consumers and their retail pharmacies to match patients with relevant clinical trials.

Following the acquisition by DrFirst, the strategy expanded to incorporate physicians more directly into the recruitment process. By delivering information about new trials and qualification requirements to providers at the point of care, the integrated solution aims to accelerate trial enrollment and enhance patient treatment options. This approach creates new points of engagement during a patient's prescription lifetime, allowing life sciences partners to reinforce critical information. The company under the leadership of its president, Joe Rector, at the time of the acquisition, emphasized the importance of coordinated communications at the point of care.

Keywords: patient recruitment, clinical trial services, patient identification, healthcare communication, CRO services, pharmaceutical services, clinical research organization, HIPAA compliant technology, de-identified patient data, patient matching, risk evaluation and mitigation strategies, market research healthcare, DrFirst, Joe Rector, patient engagement, clinical trial enrollment, point of care communication, physician network, medication management integration